In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...